These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 11466138
1. Predicting the recurrence of ventricular tachyarrhythmias from T-wave alternans assessed on antiarrhythmic pharmacotherapy: a prospective study in patients with dilated cardiomyopathy. Sakabe K, Ikeda T, Sakata T, Kawase A, Kumagai K, Tezuka N, Takami M, Nakae T, Noro M, Enjoji Y, Sugi K, Yamaguchi T. Ann Noninvasive Electrocardiol; 2001 Jul; 6(3):203-8. PubMed ID: 11466138 [Abstract] [Full Text] [Related]
2. Comparison of T-wave alternans and QT interval dispersion to predict ventricular tachyarrhythmia in patients with dilated cardiomyopathy and without antiarrhythmic drugs: a prospective study. Sakabe K, Ikeda T, Sakata T, Kawase A, Kumagai K, Tezuka N, Takami M, Nakae T, Noro M, Enjoji Y, Sugi K, Yamaguchi T. Jpn Heart J; 2001 Jul; 42(4):451-7. PubMed ID: 11693281 [Abstract] [Full Text] [Related]
5. Microvolt QRS Alternans Without Microvolt T-Wave Alternans in Human Cardiomyopathy: A Novel Risk Marker of Late Ventricular Arrhythmias. Suszko A, Nayyar S, Labos C, Nanthakumar K, Pinter A, Crystal E, Chauhan VS. J Am Heart Assoc; 2020 Sep; 9(17):e016461. PubMed ID: 32806990 [Abstract] [Full Text] [Related]
6. Microvolt T-wave alternans for the risk stratification of dangerous ventricular arrhythmias in patients with previously implanted automatic cardioverter-defibrillator. Lewandowski M, Kossuth I, Zielonka J, Wielusiński M, Kazimierczak A, Kornacewicz Jach Z, Przybycień K, Kaliszczak R. Kardiol Pol; 2011 Sep; 69(6):580-5. PubMed ID: 21678296 [Abstract] [Full Text] [Related]
8. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD. J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243 [Abstract] [Full Text] [Related]
9. The effect of procainamide on T wave alternans. Kavesh NG, Shorofsky SR, Sarang SE, Gold MR. J Cardiovasc Electrophysiol; 1999 May; 10(5):649-54. PubMed ID: 10355920 [Abstract] [Full Text] [Related]
10. Determinant of microvolt-level T-wave alternans in patients with dilated cardiomyopathy. Adachi K, Ohnishi Y, Shima T, Yamashiro K, Takei A, Tamura N, Yokoyama M. J Am Coll Cardiol; 1999 Aug; 34(2):374-80. PubMed ID: 10440148 [Abstract] [Full Text] [Related]
11. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment. Kühlkamp V, Mewis C, Mermi J, Bosch RF, Seipel L. J Am Coll Cardiol; 1999 Jan; 33(1):46-52. PubMed ID: 9935007 [Abstract] [Full Text] [Related]
12. Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction. Cantillon DJ, Stein KM, Markowitz SM, Mittal S, Shah BK, Morin DP, Zacks ES, Janik M, Ageno S, Mauer AC, Lerman BB, Iwai S. J Am Coll Cardiol; 2007 Jul 10; 50(2):166-73. PubMed ID: 17616302 [Abstract] [Full Text] [Related]
13. T wave alternans as a risk predictor in patients with cardiomyopathy and mild-to-moderate heart failure. Hennersdorf MG, Perings C, Niebch V, Vester EG, Strauer BE. Pacing Clin Electrophysiol; 2000 Sep 10; 23(9):1386-91. PubMed ID: 11025895 [Abstract] [Full Text] [Related]
14. Prognostic utility of T-wave alternans in a real-world population of patients with left ventricular dysfunction: the PREVENT-SCD study. Shizuta S, Ando K, Nobuyoshi M, Ikeda T, Yoshino H, Hiramatsu S, Kazatani Y, Yamashiro K, Okajima K, Kajiya T, Kobayashi Y, Kato T, Fujii S, Mitsudo K, Inoue K, Ito H, Haruna Y, Doi T, Nishio Y, Ozasa N, Nishiyama K, Kita T, Morimoto T, Kimura T, PREVENT-SCD Investigators. Clin Res Cardiol; 2012 Feb 10; 101(2):89-99. PubMed ID: 21960418 [Abstract] [Full Text] [Related]
15. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease. Rashba EJ, Osman AF, Macmurdy K, Kirk MM, Sarang SE, Peters RW, Shorofsky SR, Gold MR. J Cardiovasc Electrophysiol; 2004 Feb 10; 15(2):170-6. PubMed ID: 15028046 [Abstract] [Full Text] [Related]
16. Electrophysiologic study-guided amiodarone for sustained ventricular tachyarrhythmias associated with structural heart diseases. Aiba T, Yamagata K, Shimizu W, Taguchi A, Satomi K, Noda T, Okamura H, Suyama K, Aihara N, Kamakura S, Kurita T. Circ J; 2008 Jan 10; 72(1):88-93. PubMed ID: 18159106 [Abstract] [Full Text] [Related]
17. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study. Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, Libero L, Pettinati G, Molon G, Curnis A, Occhetta E, Morandi F, Ferrero P, Accardi F, ALPHA Study Group Investigators. J Am Coll Cardiol; 2007 Nov 06; 50(19):1896-904. PubMed ID: 17980258 [Abstract] [Full Text] [Related]
18. Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans. Results of a prospective, double-blind, randomized study. Klingenheben T, Grönefeld G, Li YG, Hohnloser SH. J Am Coll Cardiol; 2001 Dec 06; 38(7):2013-9. PubMed ID: 11738309 [Abstract] [Full Text] [Related]
19. Risk stratification for sudden cardiac death in dilated cardiomyopathy using microvolt-level T-wave alternans. Adachi K, Ohnishi Y, Yokoyama M. Jpn Circ J; 2001 Feb 06; 65(2):76-80. PubMed ID: 11216829 [Abstract] [Full Text] [Related]